Kemp E H, Ajjan R A, Husebye E S, Peterson P, Uibo R, Imrie H, Pearce S H, Watson P F, Weetman A P
Section of Medicine, Northern General Hospital, University of Sheffield, UK.
Clin Endocrinol (Oxf). 1998 Nov;49(5):609-13. doi: 10.1046/j.1365-2265.1998.00579.x.
Recent studies have demonstrated an association between a microsatellite polymorphism of the CTLA-4 gene, specifically a 106 base pair allele, and both Graves' disease and autoimmune hypothyroidism. The aim of the present study was to determine whether the same polymorphism of the CTLA-4 gene was associated with autoimmune Addison's disease.
We analysed a microsatellite polymorphism (variant lengths of a dinucleotide (AT)n repeat) within exon 3 of the CTLA-4 gene in the following groups: 21 English patients with non-associated Addison's disease, 18 with autoimmune polyglandular syndrome type 2 (APS2) and 173 healthy control subjects; 26 Norwegian patients with non-associated Addison's disease, 9 with autoimmune polyglandular syndrome type 1 (APS1), 17 with APS2 and 100 controls; 3 Finnish patients with non-associated Addison's disease, 5 with APS2 and 71 controls; 10 Estonian patients with non-associated Addison's disease, 2 with APS2 and 45 controls.
The CTLA-4 microsatellite gene polymorphisms were determined by polymerase chain reaction amplification of genomic DNA and resolution of the products on sequencing gels.
The frequency of the 106 base pair allele was significantly increased in the groups of English patients with either non-associated Addison's disease or APS2 (P = 0.02 and 0.04, respectively), when compared to healthy controls with no clinical evidence or family history of either Addison's disease or any other autoimmune disorder. For Norwegian patients with either non-associated Addison's disease, APS1 or APS2, there was no association (P = 0.69, 0.62 and 0.97, respectively). This was also the case for Finnish patients with either non-associated Addison's disease or APS2 (P = 0.23 and 0.28, respectively) and for Estonian patients with either non-associated Addison's disease or APS2 (P = 0.34 and 0.29, respectively).
These results indicate that differences exist in the frequency of the 106 base pair allele in different population groups and in only the English population was the 106 base pair allele associated with Addison's disease.
近期研究表明,细胞毒性T淋巴细胞相关抗原4(CTLA - 4)基因的微卫星多态性,特别是一个106个碱基对的等位基因,与格雷夫斯病和自身免疫性甲状腺功能减退症均有关联。本研究的目的是确定CTLA - 4基因的同一多态性是否与自身免疫性 Addison 病相关。
我们分析了CTLA - 4基因第3外显子内的微卫星多态性(二核苷酸(AT)n重复的可变长度),研究对象包括以下几组:21例患有非相关性Addison病的英国患者、18例患有2型自身免疫性多腺体综合征(APS2)的患者以及173名健康对照者;26例患有非相关性Addison病的挪威患者、9例患有1型自身免疫性多腺体综合征(APS1)的患者、17例患有APS2的患者以及100名对照者;3例患有非相关性Addison病的芬兰患者、5例患有APS2的患者以及71名对照者;10例患有非相关性Addison病的爱沙尼亚患者、2例患有APS2的患者以及45名对照者。
通过聚合酶链反应扩增基因组DNA并在测序凝胶上分离产物来确定CTLA - 4微卫星基因多态性。
与无Addison病临床证据或家族史以及无任何其他自身免疫性疾病家族史的健康对照者相比,患有非相关性Addison病或APS2的英国患者组中106个碱基对等位基因的频率显著增加(分别为P = 0.02和0.04)。对于患有非相关性Addison病、APS1或APS2的挪威患者,不存在关联(分别为P = 0.69、0.62和0.97)。患有非相关性Addison病或APS2的芬兰患者(分别为P = 0.23和0.28)以及患有非相关性Addison病或APS2的爱沙尼亚患者(分别为P = 0.34和0.29)的情况也是如此。
这些结果表明,不同人群组中106个碱基对等位基因的频率存在差异,并且仅在英国人群中,106个碱基对等位基因与Addison病相关。